Glumetinib Combined With Toripalimab in the Treatment of Relapsed or Metastatic Non-small Cell Lung Cancer.
Clinical trial NCT04797702 · TERMINATED
Trial details
- NCT number
- NCT04797702
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-21
- Primary completion
- 2022-11-07
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.